BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1497 related articles for article (PubMed ID: 26943133)

  • 21. Integrated analysis of
    Girard A; Rouanne M; Taconet S; Radulescu C; Neuzillet Y; Girma A; Beaufrere A; Lebret T; Le Stanc E; Grellier JF
    Eur Radiol; 2019 Aug; 29(8):4286-4293. PubMed ID: 30666449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
    Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [
    Rogasch JMM; Michaels L; Baumgärtner GL; Frost N; Rückert JC; Neudecker J; Ochsenreither S; Gerhold M; Schmidt B; Schneider P; Amthauer H; Furth C; Penzkofer T
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2140-2151. PubMed ID: 36820890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
    Shao T; Yu L; Li Y; Chen M
    Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):155-60. PubMed ID: 25800571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow.
    Rogasch JMM; Frost N; Bluemel S; Michaels L; Penzkofer T; von Laffert M; Temmesfeld-Wollbrück B; Neudecker J; Rückert JC; Ochsenreither S; Böhmer D; Amthauer H; Furth C
    Lung Cancer; 2021 Jul; 157():66-74. PubMed ID: 33994197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
    Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of mediastinal lymph node metastasis based on
    Yin G; Song Y; Li X; Zhu L; Su Q; Dai D; Xu W
    Eur Radiol; 2021 Jun; 31(6):3983-3992. PubMed ID: 33201286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M; Gallego M; Berna L; Montón C; Vigil L; Masdeu MJ; Fernández-Villar A; Botana MI; Cordovilla R; García-Luján R; Cases E; Monsó E
    BMC Pulm Med; 2016 Dec; 16(1):177. PubMed ID: 27931198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative computed tomography texture analysis: can it improve diagnostic accuracy to differentiate malignant lymph nodes?
    Shin SY; Hong IK; Jo YS
    Cancer Imaging; 2019 May; 19(1):25. PubMed ID: 31113494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients?
    Lee SW; Kim SJ
    Clin Nucl Med; 2022 May; 47(5):414-421. PubMed ID: 35234195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Investigation of the Relationship Between
    Kandemir O; Demir F
    Curr Radiopharm; 2024; 17(1):111-116. PubMed ID: 37644744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
    Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Bogaert J; Maes A; Deneffe GJ; Nackaerts KL; Verschakelen JA; Lerut TE; Mortelmans LA; Demedts MG
    J Clin Oncol; 1998 Jun; 16(6):2142-9. PubMed ID: 9626214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomic Analysis using Density Threshold for FDG-PET/CT-Based N-Staging in Lung Cancer Patients.
    Flechsig P; Frank P; Kratochwil C; Antoch G; Rath D; Moltz J; Rieser M; Warth A; Kauczor HU; Schwartz LH; Haberkorn U; Giesel FL
    Mol Imaging Biol; 2017 Apr; 19(2):315-322. PubMed ID: 27539308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: Comparison With Conventional CT and FDG PET/CT Findings.
    Nagano H; Takumi K; Nakajo M; Fukukura Y; Kumagae Y; Jinguji M; Tani A; Yoshiura T
    AJR Am J Roentgenol; 2022 Jan; 218(1):66-74. PubMed ID: 34319164
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of Dual-Timepoint
    Collarino A; Garganese G; Valdés Olmos RA; Stefanelli A; Perotti G; Mirk P; Fragomeni SM; Ieria FP; Scambia G; Giordano A; Rufini V
    J Nucl Med; 2017 Dec; 58(12):1913-1918. PubMed ID: 28546331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.
    Nguyen P; Bhatt M; Bashirzadeh F; Hundloe J; Ware R; Fielding D; Ravi Kumar AS
    Respirology; 2015 Jan; 20(1):129-37. PubMed ID: 25263085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ratio of lymph node to primary tumor SUVmax multiplied by maximal tumor diameter on positron emission tomography/integrated computed tomography may be a predictor of mediastinal lymph node malignancy in lung cancer.
    Liu Y; Tang Y; Xue Z; Yang P; Ma K; Ma G; Chu X
    Medicine (Baltimore); 2016 Nov; 95(46):e5457. PubMed ID: 27861398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
    Mallorie A; Goldring J; Patel A; Lim E; Wagner T
    Nucl Med Commun; 2017 Aug; 38(8):715-719. PubMed ID: 28658052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ
    Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.